Problem statement: Answer the MCQ question.
Query: Which compound exhibits a 35.740% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: O=C1CNC(=S)N1c1nc(-c2ccccc2)cs1
b: CCc1nnc(NC(=O)CSc2nnc3c(C)cc4c(C)ccc(C)c4n23)s1
c: CCOc1ccc(N2C(=O)CC(Sc3nc(O)c(CC)c(=O)[nH]3)C2=O)cc1
d: CN(C)C(=O)c1ccc(NC(=O)COC(=O)CC23CC4CC(CC(Br)(C4)C2)C3)cc1
Answer: a. O=C1CNC(=S)N1c1nc(-c2ccccc2)cs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1CNC(=S)N1c1nc(-c2ccccc2)cs1
O=C1CNC(=S)N1c1nc(-c2ccccc2)cs1
3-(4-phenyl-1,3-thiazol-2-yl)-2-sulfanylideneimidazolidin-4-one